Related Experiment Video
Updated: Aug 8, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the
T Yamagata1, J Nishida, S Tanaka
1Third Department of Internal Medicine, Tokyo University, Japan.
Insights
We identified a new protein, interferon consensus sequence-binding protein (ICSAT), that regulates gene expression. ICSAT acts as a repressor, suggesting a novel "differential repression" mechanism in interferon-responsive genes.
Area of Science:
- Immunology
- Molecular Biology
- Gene Regulation
Background:
- Interferon (IFN) consensus sequences (ICSs) are crucial regulatory elements in IFN-responsive genes.
- The Interferon Regulatory Factor (IRF) family plays a key role in mediating cellular responses to interferons.
- Understanding novel regulators of IFN signaling is critical for comprehending immune responses and disease pathogenesis.
Purpose of the Study:
- To isolate and characterize a novel cDNA clone encoding an IFN consensus sequence-binding protein (ICSAT).
- To investigate the expression patterns and binding affinities of ICSAT.
- To elucidate the functional role of ICSAT in regulating IFN-responsive gene expression.
Main Methods:
- Isolation of a novel cDNA clone encoding ICSAT from adult T-cell leukemia and activated T cells.
- Analysis of ICSAT expression in various T-cell lines, including HTLV-1 infected cells.
- Binding affinity studies of ICSAT to different ICSs.
- Cotransfection experiments using the N-Tera2 cell line to assess the functional role of ICSAT.
Main Results:
- ICSAT was identified as the human homolog of Pip/LSIRF and is structurally related to ICSBP.
- ICSAT expression is induced by HTLV-1 tax gene or PMA-A23187 stimulation in Jurkat cells.
- ICSAT exhibits a repressive function on gene activation induced by IFN or IRF-1.
- ICSAT demonstrates differential repression compared to IRF-2 and ICSBP on certain IFN-responsive reporter constructs.
Conclusions:
- A novel protein, ICSAT, has been identified with a role in regulating IFN-responsive genes.
- ICSAT functions as a repressor, contributing to a "differential repression" mechanism.
- This mechanism involves multiple repressor proteins with distinct repressive effects, adding complexity to IFN-mediated gene regulation.
Abstract:
We have isolated a novel cDNA clone encoding interferon (IFN) consensus sequence-binding protein in adult T-cell leukemia cell line or activated T cells (ICSAT); this protein is the human homolog of the recently cloned Pip/LSIRF. ICSAT is structurally most closely related to the previously cloned ICSBP, a member of the IFN regulatory factor (IRF) family of proteins that binds to interferon consensus sequences (ICSs) found in many promoters of the IFN-regulated genes. Among T-cell lines investigated, ICSAT was abundantly expressed in human T-cell leukemia virus type 1 (HTLV-1)-infected T cells. When the HTLV-1 tax gene was expressed or phorbol myristake acetate-A23187 stimulation was used, ICSAT expression was induced in Jurkat cells which otherwise do not express ICSAT. When the binding of ICSAT to four different ICSs was tested, the relative differences in binding affinities for those ICSs were determined. To study the functional role of ICSAT, we performed cotransfection experiments with the human embryonal carcinoma cell line N-Tera2. ICSAT was demonstrated to possess repressive function over the gene activation induced by IFN stimulation or by IRF-1 cotransfection. Such repressive function is similar to that seen in IRF-2 or ICSBP. However, we have found that ICSAT has a different repressive effect from that of IRF-2 or ICSBP in some IFN-responsive reporter constructs. These results suggest that a novel mechanism of gene regulation by "differential repression" is used by multiple members of repressor proteins with different repressive effects on the IFN-responsive genes.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi
Inhibitors of Viral Protein Synthesis

